2.92
price down icon1.02%   -0.03
after-market アフターアワーズ: 2.95 0.03 +1.03%
loading
前日終値:
$2.95
開ける:
$2.97
24時間の取引高:
3.12M
Relative Volume:
0.90
時価総額:
$774.22M
収益:
$194.75M
当期純損益:
$-51.26M
株価収益率:
-10.43
EPS:
-0.28
ネットキャッシュフロー:
$-23.38M
1週間 パフォーマンス:
+1.04%
1か月 パフォーマンス:
+3.18%
6か月 パフォーマンス:
+53.68%
1年 パフォーマンス:
+119.55%
1日の値動き範囲:
Value
$2.89
$3.10
1週間の範囲:
Value
$2.69
$3.10
52週間の値動き範囲:
Value
$1.30
$4.0787

Akebia Therapeutics Inc Stock (AKBA) Company Profile

Name
名前
Akebia Therapeutics Inc
Name
セクター
Healthcare (1140)
Name
電話
617-871-2098
Name
住所
245 FIRST STREET, CAMBRIDGE, MA
Name
職員
181
Name
Twitter
@akebiatx
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
AKBA's Discussions on Twitter

AKBA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - Specialty & Generic icon
AKBA
Akebia Therapeutics Inc
2.92 739.75M 194.75M -51.26M -23.38M -0.28
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
143.26 63.58B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.88 43.58B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.20 40.83B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
19.63 23.07B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
432.69 19.61B 3.08B 1.24B 1.07B 25.61

Akebia Therapeutics Inc Stock (AKBA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-06-04 再開されました H.C. Wainwright Buy
2025-04-28 開始されました Leerink Partners Outperform
2025-04-01 開始されました Jefferies Buy
2023-11-29 再開されました BTIG Research Buy
2023-08-28 アップグレード H.C. Wainwright Neutral → Buy
2023-05-31 アップグレード Piper Sandler Neutral → Overweight
2022-03-31 ダウングレード H.C. Wainwright Buy → Neutral
2022-03-31 ダウングレード Mizuho Buy → Neutral
2022-03-31 ダウングレード Needham Buy → Hold
2022-03-31 ダウングレード Piper Sandler Overweight → Neutral
2021-03-08 開始されました Cantor Fitzgerald Overweight
2021-01-29 ダウングレード JP Morgan Neutral → Underweight
2019-11-14 繰り返されました Needham Buy
2019-08-06 繰り返されました H.C. Wainwright Buy
2019-07-11 繰り返されました H.C. Wainwright Buy
2019-05-02 開始されました JP Morgan Overweight
2019-03-20 開始されました Citigroup Neutral
2018-09-07 再開されました Morgan Stanley Equal-Weight
2018-08-10 繰り返されました Needham Buy
2018-06-06 繰り返されました H.C. Wainwright Buy
2017-12-19 開始されました Piper Jaffray Overweight
2017-12-07 開始されました BTIG Research Buy
2017-09-15 開始されました RBC Capital Mkts Sector Perform
2017-07-10 繰り返されました H.C. Wainwright Buy
2017-04-27 繰り返されました H.C. Wainwright Buy
2017-04-27 繰り返されました Needham Buy
2016-12-27 繰り返されました H.C. Wainwright Buy
2016-12-20 繰り返されました JMP Securities Mkt Outperform
2016-11-15 開始されました Aegis Capital Buy
2016-09-29 開始されました Brean Capital Buy
2016-03-16 繰り返されました Needham Buy
2016-01-21 開始されました Credit Suisse Neutral
すべてを表示

Akebia Therapeutics Inc (AKBA) 最新ニュース

pulisher
Oct 16, 2025

Real time breakdown of Akebia Therapeutics Inc. stock performanceWeekly Trade Summary & AI Enhanced Trading Signals - newser.com

Oct 16, 2025
pulisher
Oct 16, 2025

How rising interest rates impact Akebia Therapeutics Inc. stockJuly 2025 Drop Watch & Daily Profit Focused Stock Screening - newser.com

Oct 16, 2025
pulisher
Oct 16, 2025

Will Akebia Therapeutics Inc. (AX9) stock profit from AI boomJuly 2025 Fed Impact & High Conviction Investment Ideas - newser.com

Oct 16, 2025
pulisher
Oct 15, 2025

Akebia slumps after Q4 earnings miss - MSN

Oct 15, 2025
pulisher
Oct 15, 2025

Is this a good reentry point in Akebia Therapeutics Inc.July 2025 Big Picture & Weekly Top Gainers Alerts - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Applying Elliott Wave Theory to Akebia Therapeutics Inc.2025 EndofYear Setup & Step-by-Step Swing Trade Plans - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Should I hold or sell Akebia Therapeutics Inc. stock in 2025Earnings Overview Summary & Consistent Return Strategy Ideas - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Zacks Industry Outlook Highlights Akebia Therapeutics, Ironwood Pharmaceuticals, Pyxis Oncology, Cardiol Therapeutics and Plus Therapeutics - Yahoo Finance

Oct 15, 2025
pulisher
Oct 14, 2025

Order flow analysis tools used on Akebia Therapeutics Inc.Market Weekly Review & Daily Volume Surge Signals - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

5 Small Drug Stocks to Buy as the Industry Shows Some Recovery - Zacks Investment Research

Oct 14, 2025
pulisher
Oct 13, 2025

What makes Akebia Therapeutics Inc. stock attractive to growth fundsJuly 2025 Action & Community Consensus Picks - newser.com

Oct 13, 2025
pulisher
Oct 12, 2025

Applying chart zones and confluence areas to Akebia Therapeutics Inc.Quarterly Market Summary & Daily Oversold Stock Bounce Ideas - newser.com

Oct 12, 2025
pulisher
Oct 12, 2025

What to expect from Akebia Therapeutics Inc. in the next 30 daysCPI Data & Fast Gaining Stock Strategy Reports - newser.com

Oct 12, 2025
pulisher
Oct 10, 2025

Akebia Therapeutics Achieves Multibagger Status with 123.31% Stock Increase Over Past Year - Markets Mojo

Oct 10, 2025
pulisher
Oct 10, 2025

Can technical indicators confirm Akebia Therapeutics Inc.’s reversalJuly 2025 PreEarnings & Real-Time Volume Surge Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Akebia Therapeutics, Inc. (AKBA) Investor Outlook: Potential 156% Upside Sparks Interest - DirectorsTalk Interviews

Oct 10, 2025
pulisher
Oct 10, 2025

What machine learning models say about Akebia Therapeutics Inc.Quarterly Trade Summary & High Win Rate Trade Tips - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

How Akebia Therapeutics Inc. stock performs in interest rate cycles2025 Risk Factors & Growth-Oriented Investment Plans - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Why Akebia Therapeutics Inc. (AX9) stock is a strong buy callQuarterly Portfolio Summary & Smart Allocation Stock Tips - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

How Akebia Therapeutics Inc. stock reacts to inflationary pressuresTrade Ideas & Fast Exit and Entry Strategy Plans - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Published on: 2025-10-09 05:00:40 - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Can Akebia Therapeutics Inc. (AX9) stock resist broad market declinesQuarterly Trade Summary & AI Powered Market Entry Ideas - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

How Akebia Therapeutics Inc. (AX9) stock moves in volatile trading sessions2025 Institutional Moves & Daily Chart Pattern Signals - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

Weiss Ratings Reiterates Sell (D-) Rating for Akebia Therapeutics (NASDAQ:AKBA) - MarketBeat

Oct 08, 2025
pulisher
Oct 08, 2025

Is Intellia Therapeutics (NTLA) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Oct 08, 2025
pulisher
Oct 07, 2025

Akebia Therapeutics, Inc.'s (NASDAQ:AKBA) Profit Outlook - simplywall.st

Oct 07, 2025
pulisher
Oct 06, 2025

What drives Akebia Therapeutics Inc stock priceInsider Buying Signals & Free Daily Market Summary and Trend Reports - earlytimes.in

Oct 06, 2025
pulisher
Oct 03, 2025

Published on: 2025-10-03 06:28:34 - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Is Akebia Therapeutics Inc. stock poised for growthRate Hike & Weekly High Conviction Ideas - newser.com

Oct 03, 2025

Akebia Therapeutics Inc (AKBA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$20.52
price up icon 0.05%
$10.10
price up icon 1.20%
drug_manufacturers_specialty_generic RDY
$14.22
price up icon 1.07%
$59.15
price down icon 5.75%
$137.52
price down icon 0.15%
$432.69
price up icon 0.12%
大文字化:     |  ボリューム (24 時間):